FFR- Versus Angiography-Guided Revascularization for Nonculprit Stenosis in STEMI and Multivessel Disease

医学 狼牙棒 部分流量储备 心脏病学 内科学 血运重建 心肌梗塞 罪魁祸首 狭窄 血管造影 冠状动脉疾病 冠状动脉造影 经皮冠状动脉介入治疗
作者
Ayman Elbadawi,Alexander Dang,Mohamed Hamed,Mennaallah Eid,Meghana Prakash Hiriyur Prakash,Mohammed Saleh,Mohamed M. Gad,Mamas A. Mamas,Faisal Rahman,Islam Y. Elgendy
出处
期刊:Jacc-cardiovascular Interventions [Elsevier BV]
卷期号:15 (6): 656-666 被引量:27
标识
DOI:10.1016/j.jcin.2022.01.002
摘要

OBJECTIVES The aim of this study was to examine the efficacy and safety of fractional flow reserve (FFR)-guided versus angiography-guided approaches for nonculprit stenosis among patients with acute ST-segment elevation myocardial infarction (STEMI) and multivessel disease.BACKGROUND The optimal strategy to guide revascularization of nonculprit stenosis among patients with STEMI and multivessel disease remains uncertain.METHODS Electronic databases were searched for randomized trials evaluating the outcomes of culprit-only revascularization, angiography-guided complete revascularization (CR), or FFR-guided CR.A pairwise meta-analysis comparing CR versus culprit-only revascularization and a network meta-analysis comparing the different revascularization techniques were conducted.The primary outcome was major adverse cardiac events (MACE). RESULTSThe analysis included 11 trials with 8,195 patients.CR (ie, angiography-guided or FFR-guided CR) was associated with a lower incidence of MACE (odds ratio [OR]: 0.46; 95% CI: 0.35 to 0.59), cardiovascular mortality (OR: 0.63; 95% CI: 0.41 to 0.98), recurrent myocardial infarction (OR: 0.67; 95% CI: 0.48 to 0.95), and repeat ischemia-driven revascularization (OR: 0.26; 95% CI: 0.19 to 0.35).Network meta-analysis demonstrated that the incidence of MACE was lower with both angiography-guided CR (OR: 0.43; 95% CI: 0.31 to 0.58) and FFR-guided CR (OR: 0.52; 95% CI: 0.35 to 0.78) compared with a culprit-only approach, while there was no difference in risk for MACE between angiography-guided and FFR-guided CR (OR: 0.81; 95% CI: 0.51 to 1.29).CONCLUSIONS Among patients with STEMI and multivessel disease, CR, with angiographic or FFR guidance for nonculprit stenosis, was associated with lower incidence of adverse events compared with culprit-only revascularization.FFR-guided CR was not superior to angiography-guided CR in reducing the incidence of adverse events.Future studies investigating other tools to risk-stratify nonculprit stenoses are encouraged.(
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研友_VZG7GZ应助积极灵薇采纳,获得10
刚刚
JamesPei应助无限飞丹采纳,获得10
刚刚
独特乘云发布了新的文献求助10
刚刚
科研通AI2S应助科研通管家采纳,获得10
刚刚
科目三应助科研通管家采纳,获得10
刚刚
酷波er应助科研通管家采纳,获得10
刚刚
科研通AI5应助科研通管家采纳,获得10
刚刚
搜集达人应助科研通管家采纳,获得10
刚刚
CAOHOU应助科研通管家采纳,获得10
1秒前
1秒前
CodeCraft应助科研通管家采纳,获得10
1秒前
CodeCraft应助科研通管家采纳,获得10
1秒前
Noyo应助科研通管家采纳,获得10
1秒前
科研通AI2S应助科研通管家采纳,获得10
1秒前
tramp应助科研通管家采纳,获得10
1秒前
英俊的铭应助科研通管家采纳,获得10
1秒前
tramp应助科研通管家采纳,获得10
1秒前
英姑应助科研通管家采纳,获得10
1秒前
1秒前
1秒前
2秒前
领导范儿应助Nozomi采纳,获得10
4秒前
小马甲应助YJ888采纳,获得10
4秒前
香蕉觅云应助jialiu采纳,获得10
4秒前
cosmos完成签到,获得积分10
5秒前
大个应助独特乘云采纳,获得10
6秒前
6秒前
小晓发布了新的文献求助10
6秒前
wonder123发布了新的文献求助10
8秒前
老实起哞完成签到,获得积分10
8秒前
10秒前
11秒前
gsj发布了新的文献求助10
12秒前
13秒前
所所应助wonder123采纳,获得10
13秒前
14秒前
14秒前
14秒前
田様应助忆茶戏采纳,获得10
14秒前
wss完成签到,获得积分10
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989444
求助须知:如何正确求助?哪些是违规求助? 3531531
关于积分的说明 11254250
捐赠科研通 3270191
什么是DOI,文献DOI怎么找? 1804901
邀请新用户注册赠送积分活动 882105
科研通“疑难数据库(出版商)”最低求助积分说明 809174